Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants
Clinical trial NCT00750893 · COMPLETED
Trial details
- NCT number
- NCT00750893
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-09-02
- Primary completion
- 2013-06-15
- Enrollment
- 3111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.